Proton Radiotherapy for Upper Gastrointestinal Malignancies
The primary objectives are to determine feasibility and the acute toxicity profile of proton therapy with concurrent continuous infusion 5-FU chemotherapy. Secondary objectives are to determine late toxicities and to generate preliminary data on clinical efficacy.
Gastrointestinal Cancer
RADIATION: Proton therapy
Serious Adverse Events, Serious Adverse Events preventing more than 25% of planned treatments using proton radiotherapy., 90 days|Acute Toxicity, Measured by experience of adverse events, 90 days
This protocol invites patients with cancer of the upper digestive tract who will receive simultaneous proton radiation therapy and chemotherapy. The purpose of this study is to use a newer form of radiation therapy called proton radiation and to determine if its use is safe and effective in people with this type of cancer. Doctors will assess the safety of this method of treatment, record the side effects participants experience while receiving the standard dose of proton radiation.